Brainstorming on Endo Bronchial Ultrasound (EBUS) Technology at Himalayan Hospital

Published on: May 30, 2023

Brainstorming on Endo Bronchial Ultrasound (EBUS) Technology at Himalayan Hospital

A one-day workshop on Endo Bronchial Ultrasound (EBUS) technique was organized by the Department of Chest and Respiratory Diseases, Himalayan Institute of Medical Sciences.

Experts from across the country described the EBUS technique as effective in the treatment of patients.

Inaugurating the workshop, Vice-Chancellor SRHU, Dr. Vijendra Chauhan said that with time, there has been a change in the techniques used in the treatment of chest and respiratory diseases. “The aim of this type of workshop is to enable doctors and technicians related to this field, share their experiences and eventually make use of the latest benefits in the treatment of patients.

Head of the Department, Dr.Rakhi Khanduri said that bronchoscopy is now being done with state-of-the-art Endo Bronchial Ultrasound (EBUS) Technology for lung examination of patients at Himalayan Hospital Jolly Grant. Due to this, the reports related to the investigation of the patients become clearer and thereby helpful in the treatment.

Dr. Sushant Khanduri, Secretary of the organizing committee, stated that the problem of lumps in the middle part of the lungs (mediastinum), apart from TB, could sometimes cause cancer. In such a situation, to clarify the situation, biopsy is undertaken by taking samples. Due to the presence of food pipe, heart and various glands in this very delicate part, so far the patient had to be operated upon to take the sample. But now the Endo Bronchial Ultrasound (EBUS) technique is effective in taking samples without surgery.

Dr. Varuna Jethani informed that Dr. Deepak Talwar of Metro Hospital, Noida was the course director of this master class. Dr. Manoj Kumar and Dr. Rahul Gupta shared that experts from Uttarakhand, Delhi, Noida, Chandigarh, Lucknow, Nagpur and Mangalore participated in the workshop.

During the workshop Chief Medical Superintendent Dr.SL Jethani and Dr. Mushtaq Ahmed were present.

e1.jpg
e2.jpg
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.